KBC Group NV Sells 252,416 Shares of The Cooper Companies, Inc. $COO

KBC Group NV lowered its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 75.3% during the 1st quarter, Holdings Channel.com reports. The institutional investor owned 82,600 shares of the medical device company’s stock after selling 252,416 shares during the period. KBC Group NV’s holdings in Cooper Companies were worth $5,906,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. SEB Asset Management AB purchased a new stake in Cooper Companies in the first quarter worth about $22,823,000. Swiss National Bank grew its holdings in shares of Cooper Companies by 5.8% during the 1st quarter. Swiss National Bank now owns 575,200 shares of the medical device company’s stock worth $41,127,000 after acquiring an additional 31,500 shares during the period. AIA Group Ltd grew its holdings in shares of Cooper Companies by 53.9% during the 1st quarter. AIA Group Ltd now owns 37,278 shares of the medical device company’s stock worth $2,665,000 after acquiring an additional 13,052 shares during the period. Heartland Advisors Inc. raised its position in shares of Cooper Companies by 18.4% in the 1st quarter. Heartland Advisors Inc. now owns 221,656 shares of the medical device company’s stock worth $15,848,000 after acquiring an additional 34,393 shares in the last quarter. Finally, Kera Capital Partners Inc. lifted its stake in shares of Cooper Companies by 85.8% in the 1st quarter. Kera Capital Partners Inc. now owns 4,939 shares of the medical device company’s stock valued at $353,000 after purchasing an additional 2,281 shares during the period. 24.39% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently weighed in on the company. Piper Sandler set a $86.00 price target on Cooper Companies and gave the stock an “overweight” rating in a research note on Monday, June 1st. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. BNP Paribas Exane reduced their target price on shares of Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a research report on Monday, June 8th. Citigroup reiterated a “neutral” rating and issued a $76.00 price target (up from $69.00) on shares of Cooper Companies in a research note on Wednesday, July 8th. Finally, KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a research report on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, five have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $81.85.

Cooper Companies Stock Performance

Shares of Cooper Companies stock opened at $70.23 on Friday. The stock has a market cap of $13.70 billion, a price-to-earnings ratio of 59.52, a PEG ratio of 1.84 and a beta of 0.84. The firm’s 50-day moving average is $67.13 and its 200 day moving average is $72.21. The Cooper Companies, Inc. has a 1 year low of $58.89 and a 1 year high of $89.83. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. During the same period last year, the business earned $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Sell-side analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.